Terumo had 29 patents in future of work during Q4 2023. Terumo Corp’s patents in Q4 2023 focus on innovative systems and methods for treating biological fluids, separating components from multi-component fluids, positioning disposables in medical devices, and culturing cells. These patents include technologies such as flow cells for pathogen inactivation, separation vessels for plasma extraction, cell culturing systems with gas component measurement capabilities, and male connectors for connecting to female connectors with elastic valve bodies. GlobalData’s report on Terumo gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Terumo grant share with future of work as a theme is 27% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Flow cell (Patent ID: US20230405204A1)
See Also:
The patent filed by Terumo Corp describes embodiments for treating a fluid, particularly a biological fluid, using a flow cell with manipulation elements to expose the fluid to energy as it flows through the cell. The main focus is on inactivating pathogens present in the fluid. The flow cell consists of various channels, splitters, elbows, and recombiners to facilitate the manipulation of the fluid. The dimensions of the channels range between 0.5 mm and 5 mm, with specific dimensions specified for optimal performance.
The flow cell design includes multiple components such as elbows and recombiners to ensure efficient manipulation of the fluid. The use of polymeric materials, either rigid or flexible, in constructing the flow cell is highlighted, with the requirement for at least one sheet to be light transmissive. The dimensions of the channels are crucial, falling within the range of 0.6 mm to 3 mm, with specific ranges like 0.7 mm to 2 mm and 0.75 mm to 1.5 mm specified for certain channels. Overall, the patent focuses on a detailed design for a flow cell that can effectively treat biological fluids by inactivating pathogens as they pass through the system.
To know more about GlobalData’s detailed insights on Terumo, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
